Fusion protein Cys–Asn–Gly–Arg–Cys–Gly–TNFα (NGR-TNFα), which targets the tumor vasculature delivering low amounts of TNFα, activates endothelial cells and allows CD8+ T lymphocytes infiltration (268). The gene discussed is TNF; the disease is neoplasm.